Biomedical Engineering Reference
In-Depth Information
25
7
6
20
5
15
4
3
10
2
5
1
0
0
0
10
20
30
40
50
0
10
20
30
40
50
A
B
C
α
concentration (nM)
C
α
concentration (nM)
2
4
1.9
3.5
1.8
3
1.7
2.5
1.6
2
1.5
1.5
1.4
1.3
1.2
1
0.5
30
40
50
0
10
20
0
10
20
30
40
50
C
D
C
concentration (nM)
C
concentration (nM)
α
α
7
2.9
2.85
6
2.8
5
2.75
4
2.7
3
2.65
2
2.6
1
2.55
0
2.5
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
2
0
10
20
30
40
50
E
F
Figure 4.2
(a) Increase in the binding rate coefficient, k 1 with an increase in the C
Fractal dimension, D f1
C
α
concentration (nM)
concentration (in nM)
in solution. (b) Increase in the binding rate coefficient, k 2 , with an increase in the C
a
concentration
(in nM) in solution. (c) Increase in the dissociation rate coefficient, k 2 , with an increase in the
a
C
concentration (in nM) in solution. (d) Increase in the fractal dimension, D f1 with an increase in
the C
a
concentration (in nM) in solution. (e) Increase in the fractal dimension, D f2 with an
increase in the C
a
concentration (in nM) in solution. (f) Increase in the binding rate coefficient,
k 1 with an increase in the fractal dimension, D f1 .
a
Continued
Search WWH ::




Custom Search